Immunogenicity and Safety of Live Attenuated Varicella Vaccine in Children and Youth With Solid Organ Transplants in Canada: A Canadian Immunization Research Network Study
Open Access
- 5 April 2026
- journal article
- research article
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (4) , e70314
Abstract
Introduction: Children with solid organ transplants (SOT) face higher risks of severe disease from varicella‐zoster virus (VZV). Although some guidelines recommend live attenuated varicella vaccine (LAVV) for select children post SOT, further real‐world vaccine immunogenicity and safety data are needed. Methods: A prospective observational study was conducted at 4 Canadian centres from 2020 to 2023. Children who were 1–19 years, VZV IgG negative, > 1 year post liver, kidney, or heart transplant, and were receiving LAVV as part of clinical care in accordance with centre‐specific criteria were eligible for inclusion. Measurement of VZV IgG was recommended post‐vaccination with LAVV. Adverse events following immunization (AEFIs) were captured via telephone survey and chart review. Results: Fifty‐six pediatric SOT recipients (51 liver, 3 kidney, and 2 heart) received ≥ 1 dose of LAVV. Serology after the last post‐transplant dose of LAVV was available for 43/56 (77%) participants; 39/43 (91%) seroconverted to positive VZV IgG (12/16 after 1 post‐transplant dose, 26/30 after 2 doses and 1/1 after 3 doses). Among 56 dose 1 recipients, 6 (11%) experienced an AEFI requiring medical attention. Four had rash: 3 with varicella‐like rash (1/3 confirmed vaccine‐strain varicella) and none required antivirals. Two had acute rejection 4–5 weeks after LAVV. Two of 38 (5%) dose 2 recipients had an AEFI requiring medical attention, with one serious AEFI 7 weeks after LAVV that was not deemed vaccine‐related after careful review. Conclusions: LAVV was immunogenic and generally well tolerated in our cohort of patients. Post‐SOT LAVV should be considered for select VZV seronegative children with close follow‐up .Keywords
Funding Information
- Canadian Institutes of Health Research
- Public Health Agency of Canada
- Canadian Donation and Transplantation Research Program
- Canadian Immunization Research Network
- BC Children's Hospital
This publication has 27 references indexed in Scilit:
- Algorithm to assess causality after individual adverse events following immunizationsVaccine, 2012
- Influenza Vaccination in the Organ Transplant Recipient: Review and Summary RecommendationsAmerican Journal of Transplantation, 2011
- Vaccination status in pediatric liver transplant candidatesPediatric Transplantation, 2009
- The Safety Profile of Varicella Vaccine: A 10‐Year ReviewThe Journal of Infectious Diseases, 2008
- Safety and Immunogenicity of Varicella-Zoster Virus Vaccine in Pediatric Liver and Intestine Transplant RecipientsAmerican Journal of Transplantation, 2006
- Varicella‐zoster infection in pediatric solid‐organ transplant recipients:A hospital‐based study in the prevaricella vaccine eraPediatric Transplantation, 2001
- The Immunization Monitoring Program Active (IMPACT) prospective five year study of Canadian children hospitalized for chickenpox or an associated complicationThe Pediatric Infectious Disease Journal, 2000
- Outcome of chickenpox in 66 pediatric renal transplant recipientsThe Journal of Pediatrics, 1997
- Varicella and Zoster in Children After Kidney Transplantation: Long-term Results of VaccinationPediatrics, 1997
- Attenuated varicella virus vaccine in children with renal transplantsPediatric Nephrology, 1994